Clinical trial
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in…
NCT00072215 · Alliance for Clinical Trials in Oncology, Other · Terminated
Key facts
| NCT number | NCT00072215 |
|---|---|
| Title | Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors |
| Official title | A Randomized Phase III Study of Paclitaxel, Ifosfamide and Cisplatin Versus Vinblastine, Ifosfamide and Cisplatin as Second-Line Therapy for Patients With Relapsed/Resistant Germ Cell Tumors |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor |
| Intervention type | Drug |
| Interventions | cisplatin, ifosfamide, paclitaxel, vinblastine |
| Enrollment | 1 |
| Start date | Apr 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Nov 6, 2003 |
| Last update posted | Jul 4, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: